Development and Validation of a Nomogram for Predicting 28-Day Mortality on Admission in Elderly Patients with Severe Community-Acquired Pneumonia

DOI: https://doi.org/10.2147/JIR.S369319

IF: 4.5

2022-07-21

Journal of Inflammation Research

Abstract:Yansha Song, 1, &ast Xiaocen Wang, 1, &ast Ke Lang, 1, &ast Tingting Wei, 1 Jinlong Luo, 1 Yuanlin Song, 1, 2 Dong Yang 1, 2 1 Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; 2 Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dong Yang; Yuanlin Song, Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, People's Republic of China, Tel +86 21 64041990, Email ; Introduction: There were few studies on the mortality of severe community-acquired pneumonia (SCAP) in elderly people. Early prediction of 28-day mortality of hospitalized patients will help in the clinical management of elderly patients (age ≥ 65 years) with SCAP, but a prediction model that is reliable and valid is still lacking. Methods: The 292 elderly patients with SCAP met the criteria defined by the American Thoracic Society from 33 hospitals in China. Clinical parameters were analyzed by the use of univariable and multivariable logistic regression analysis. A nomogram to predict the 28-day mortality in elderly patients with SCAP was constructed and evaluated using the area under the receiver operating characteristic curve (AUC) and internally verified using the Bootstrap method. Results: A total of 292 elderly patients (227 surviving and 65 died within 28 days) were included in the analysis. Age, Glasgow score, blood platelet, and blood urea nitrogen values were found to be significantly associated with 28-day mortality in elderly patients with SCAP. The AUC of the nomogram was 0.713 and the calibration curve for 28-day mortality also showed high coherence between the predicted and actual probability of mortality. Conclusion: This study provides a nomogram containing age, Glasgow score, blood platelet, and blood urea nitrogen values that can be conveniently used to predict 28-day mortality in elderly patients with SCAP. This model has the potential to assist clinicians in evaluating prognosis of patients with SCAP. Keywords: severe community-acquired pneumonia, 28-day mortality prediction model, nomogram Community acquired pneumonia (CAP) continues to be a major cause of morbidity and mortality in adults despite advances in antibiotic treatment. 1,2 Elderly people with pneumonia had high incidence and risk of death, almost one-half of the total hospitalizations for CAP occurred in patients over 65 years old in developed countries. 3 The severity of CAP also increases with age, which is primarily due to impaired gag reflex, decreased mucociliary function, waning immunity and degrees of cardiopulmonary dysfunction. 4 Three criteria including age, the severity of pneumonia at presentation and the presence of underlying diseases proposed by the American Thoracic Association are used to define appropriate empirical treatment of CAP. 5 However, some elderly patients with lower respiratory tract infection have atypical symptoms, 6 increasing the chance of delay in diagnosis and treatment which leads to disease progression. 7,8 Previous study reported that the annual cost of treating patients aged ≥65 years with pneumonia was 3.6 billion for those aged <65 years with pneumonia. 9 Few previous studies focused on elderly patients, although they represented a significant portion of patients with CAP, ie, 11.0–25.3%. 10–12 Early identification of factors related to poor prognosis might prevent severe or critical outcomes, such as death, and provide related data for physicians to make optimal clinical decisions. Therefore, there is an urgent need to establish a model for predicting prognosis in elderly patients with severe community-acquired pneumonia (SCAP). The nomogram represents a visual statistical model that integrates multiple risk factors for predicting the outcome of a disease. 13 The aim of our study was to establish a nomogram that could incorporate demographics, clinical characteristics and laboratory parameters to predict the prognosis of elderly patients (≥65 years) admitted for SCAP. Subjects were derived from a randomized, double-blind, placebo-controlled trial consisting of 710 patients with SCAP who met SCAP criteria defined by the American Thoracic Society, 14 between October 2014 and January 2016, at 33 public tertiary teaching hospitals in China. The methods and main results of this study were previously published.<sup -Abstract Truncated-

immunology